September 23rd, 2024 | 12:30 noon – 01:30 pm PT
Palm Room 5-6, Town and Country Resort, San Diego, California, USA
Session description:
The presentation will discuss the continued evaluation of emka’s non-invasive impedance system for respiratory assessment, using the emkaPACK5 Jacketed Telemetry System.
Through standard external ECG leads, both ECG and external respiratory impedance data will be assessed with optimized lead placement using positive control agents. The volume calibration of the system will also be discussed and analyzed.
Educational Learning Objective
Highlight the 3Rs of animal research through combined evaluation of safety pharmacology endpoints within a toxicology (noninvasive) setting.
Offer a novel method of ambulatory respiratory collection that is not reliant on band stability.
Illustrate methods to recover data and potentially mitigate repeat study (and use of animals) due to improper pneumotach calibrations.
Dr. Ken Kearney obtained his Bachelor of Science in Biology from Ashland University in 2005.
In 2006, he began his career as a biologist at WIL Research in Ashland, OH. During his tenure within the cardiovascular pharmacology group, he has held roles of data analyst and project leader where he was responsible for qualitative and quantitative measurement of physiological signals. In 2010, he moved to the Study Director position.
Today, Dr. Kearney is the Director of Pharmacology and Discovery Services at Charles River Laboratories ASH (formerly WIL Research). He actively contributes to the Safety Pharmacology Society as a valued member and holds honors of Diplomat of Safety Pharmacology. He is currently involved in the SPS ECG and EEG certificate course planning groups.
With 40 published abstracts and 14 professional presentations, Dr. Kearney makes significant contributions to the scientific community.
